MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill

President Trump's eleventh-hour signature on the FDA Reauthorization Act puts into play about $1bn in device user-fee collections from industry through FY 2022, new US FDA performance goals and a range of device process enhancements and reforms supported by industry.

[Editors' note:Follow progress with legislation impacting the device and diagnostics industry with Medtech Insight's US Congress Tracker.]

President Trump quietly signed the FDA Reauthorization Act Aug. 18, authorizing about $1bn in device user-fee collections over...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Legislation

More from Policy & Regulation